Pediatric Diabetes on the Rise : Trends in Incident Diabetes During the COVID-19 Pandemic
© The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society..
Context: The effects of the coronavirus disease 2019 (COVID-19) pandemic on the incident cases of pediatric type 1 diabetes (T1D) and type 2 diabetes (T2D) are not clear.
Objective: To identify trends in incidence and presentation of pediatric new-onset T1D and T2D during the COVID-19 pandemic.
Methods: A retrospective chart review was conducted. Demographics, anthropometrics, and initial laboratory results from patients ages 0 through 21 years who presented with new-onset diabetes to a pediatric tertiary care center were recorded.
Results: During the pandemic, incident cases of pediatric T1D increased from 31 in each of the prior 2 years to 46; an increase of 48%. Incident cases of pediatric T2D increased by 231% from 2019 to 2020. The number of incident cases of pediatric T2D increased significantly more than the number of incident cases of pediatric T1D (P = 0.009). Patients with T2D were more likely to present in diabetic ketoacidosis (DKA), though this was not statistically significant (P = 0.093). Severe DKA was higher compared with moderate DKA (P = 0.036) in incident cases of pediatric T2D. During the pandemic, for the first time, incident cases of T2D accounted for more than one-half of all newly diagnosed pediatric diabetes cases (53%).
Conclusions: There were more incident pediatric T1D and T2D cases as well as an increase in DKA severity in T2D at presentation during the COVID-19 pandemic. More importantly, incident T2D cases were higher than the incident T1D during the pandemic. This clearly suggests a disruption and change in the pediatric diabetes trends with profound individual and community health consequences.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:6 |
---|---|
Enthalten in: |
Journal of the Endocrine Society - 6(2022), 4 vom: 01. Apr., Seite bvac024 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Modarelli, Rachel [VerfasserIn] |
---|
Links: |
---|
Themen: |
COVID-19 |
---|
Anmerkungen: |
Date Revised 11.03.2022 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.1210/jendso/bvac024 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM337966559 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM337966559 | ||
003 | DE-627 | ||
005 | 20231225235619.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1210/jendso/bvac024 |2 doi | |
028 | 5 | 2 | |a pubmed24n1126.xml |
035 | |a (DE-627)NLM337966559 | ||
035 | |a (NLM)35265783 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Modarelli, Rachel |e verfasserin |4 aut | |
245 | 1 | 0 | |a Pediatric Diabetes on the Rise |b Trends in Incident Diabetes During the COVID-19 Pandemic |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 11.03.2022 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a © The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. | ||
520 | |a Context: The effects of the coronavirus disease 2019 (COVID-19) pandemic on the incident cases of pediatric type 1 diabetes (T1D) and type 2 diabetes (T2D) are not clear | ||
520 | |a Objective: To identify trends in incidence and presentation of pediatric new-onset T1D and T2D during the COVID-19 pandemic | ||
520 | |a Methods: A retrospective chart review was conducted. Demographics, anthropometrics, and initial laboratory results from patients ages 0 through 21 years who presented with new-onset diabetes to a pediatric tertiary care center were recorded | ||
520 | |a Results: During the pandemic, incident cases of pediatric T1D increased from 31 in each of the prior 2 years to 46; an increase of 48%. Incident cases of pediatric T2D increased by 231% from 2019 to 2020. The number of incident cases of pediatric T2D increased significantly more than the number of incident cases of pediatric T1D (P = 0.009). Patients with T2D were more likely to present in diabetic ketoacidosis (DKA), though this was not statistically significant (P = 0.093). Severe DKA was higher compared with moderate DKA (P = 0.036) in incident cases of pediatric T2D. During the pandemic, for the first time, incident cases of T2D accounted for more than one-half of all newly diagnosed pediatric diabetes cases (53%) | ||
520 | |a Conclusions: There were more incident pediatric T1D and T2D cases as well as an increase in DKA severity in T2D at presentation during the COVID-19 pandemic. More importantly, incident T2D cases were higher than the incident T1D during the pandemic. This clearly suggests a disruption and change in the pediatric diabetes trends with profound individual and community health consequences | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a diabetic ketoacidosis | |
650 | 4 | |a pediatric diabetes | |
650 | 4 | |a type 1 diabetes | |
650 | 4 | |a type 2 diabetes | |
700 | 1 | |a Sarah, Salma |e verfasserin |4 aut | |
700 | 1 | |a Ramaker, Megan E |e verfasserin |4 aut | |
700 | 1 | |a Bolobiongo, Mboli |e verfasserin |4 aut | |
700 | 1 | |a Benjamin, Robert |e verfasserin |4 aut | |
700 | 1 | |a Gumus Balikcioglu, Pinar |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of the Endocrine Society |d 2017 |g 6(2022), 4 vom: 01. Apr., Seite bvac024 |w (DE-627)NLM272607959 |x 2472-1972 |7 nnns |
773 | 1 | 8 | |g volume:6 |g year:2022 |g number:4 |g day:01 |g month:04 |g pages:bvac024 |
856 | 4 | 0 | |u http://dx.doi.org/10.1210/jendso/bvac024 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 6 |j 2022 |e 4 |b 01 |c 04 |h bvac024 |